Mineralys Therapeutics(MLYS) - 2024 Q2 - Earnings Call Presentation

Mineralys Therapeutics, Inc. ©2023. All Rights Reserved. 1 Targeting Aldosterone in the Treatment of Cardiorenal Diseases J une 2024 F o r w a r d-L o o k i n g S t a t e m e n t s a n d M a r k e t D a t a We caution you that this presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, business strategy, research and development plans, th ...